Valeo Pharma Inc.
VPHIF
$0.0469
-$0.0471-50.11%
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.98M | -5.76M | -5.09M | -6.81M | -4.38M |
| Total Depreciation and Amortization | 457.20K | 469.40K | 435.50K | 481.60K | 472.30K |
| Total Amortization of Deferred Charges | -- | -- | 47.40K | 71.40K | -- |
| Total Other Non-Cash Items | 2.74M | 1.63M | 1.03M | 1.30M | 551.70K |
| Change in Net Operating Assets | 3.11M | 1.21M | 4.79M | 2.99M | 2.41M |
| Cash from Operations | 329.40K | -2.44M | 1.21M | -1.97M | -943.80K |
| Capital Expenditure | -- | -29.50K | -37.00K | -21.40K | -83.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 977.90K | 203.70K | -3.68M | -- |
| Cash from Investing | -- | 948.50K | 166.70K | -3.70M | -83.20K |
| Total Debt Issued | -- | -- | 680.00K | 2.07M | 1.30M |
| Total Debt Repaid | -244.00K | -800.00K | -211.00K | -719.00K | -57.00K |
| Issuance of Common Stock | -- | -- | -- | 3.92M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.00K | -40.00K | -9.00K | -218.00K | -- |
| Cash from Financing | -181.10K | -619.00K | 340.70K | 3.72M | 931.80K |
| Foreign Exchange rate Adjustments | 23.40K | 127.50K | -172.60K | 273.90K | -161.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.60K | -1.99M | 1.54M | -1.67M | -257.10K |
